Under ACE inhibition, both in the minimal change disease and in the “FSGS/IgAN/ GN,” a significant difference in uEGF/uCreat was still seen compared to healthy controls as well as in comparison to Alport syndrome (Table 6C). Here, ACE is linked to ganglioneuroma.